🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the combination of Pegylated Alfa ...
Status
Terminated
Location
Baylor College of Medicine - Methodist Hospital
Start Date
2007-05
Trial ID
NCT00522249
Treatments Being Tested
The purpose of this study is to (1) determine the effects of the herbal for...
Status
Withdrawn
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00633230
This phase 2b study will evaluate the efficacy and safety of 16 and 24 week...
Status
Completed
Location
Mayo Clinic
Start Date
2010-10
Trial ID
NCT01225380
The purpose of this study is to evaluate if a 12-week total regimen of tela...
Status
Terminated
Location
Multiple Locations
Start Date
2011-11
Trial ID
NCT01459913
Treatments Being Tested
This is a 60-to-72 week multicenter study to evaluate Infergen and Ribaviri...
Status
Terminated
Location
Atlantic Gastroenterology Associates
Start Date
2007-02
Trial ID
NCT00456248
Treatments Being Tested
Current clinical practices has shown promising prospects of the therapy str...
Status
Completed
Location
Beijing Ditan Hospital, Capital Medical University
Start Date
2019-12-04
Trial ID
NCT04846491
This study is a multi-center, randomized, open-label and positive controlle...
Status
Completed
Location
302 Military Hospital
Start Date
2010-07
Trial ID
NCT01140997
Treatments Being Tested
The purpose of this study is to determine whether BMS-790052 added to Pegin...
Status
Completed
Location
Alabama Liver & Digestive Specialists (Alds)
Start Date
2010-08
Trial ID
NCT01170962
Treatments Being Tested
The purpose of this study is to evaluate the impact of a physician directed...
Status
Completed
Location
California Liver Institute
Start Date
2011-12
Trial ID
NCT01405027
Treatments Being Tested
This is a Phase 2b, Randomized, Double-Blind, Placebo-Controlled Trial Eval...
Status
Completed
Location
Multiple Locations
Start Date
2011-07
Trial ID
NCT01356160
Treatments Being Tested